1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Mechanistic Studies of the Interaction between SARS-Co-V-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (RO1 Clinical Trial Optional) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This funding opportunity supports basic and clinical mechanistic research on SARS-CoV-2 and COVID-19 susceptibility, routes of infection, disease course, morbidity, and mortality in individuals with pre-existing diseases or those experiencing acute or chronic outcomes in organs,…
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NOT-DK-21-001: Notice of Pre-Application Webinar for RFA-DK-20-021, Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) Notice of Pre-Application Webinar for RFA-DK-20-021, Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) RFA-DK-20-021 - Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) National Institute of Diabetes and Digestive and Kidney Diseases ( NIDDK ) The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will host a pre-application webinar on November 9, 2020 from 3:00 PM - 4:00 PM EST (Eastern Standard Time) for the Funding Opportunity Announcement (FOA) RFA-DK-20-021 “Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)” for those interested in learning more about the FOA.
The webinar is open to all prospective applicants, although participation in the webinar is not required to submit an application to RFA-DK-20-021. NIDDK staff members involved in the FOA will provide a brief overview of RFA-DK-20-021 for potential applicants by explaining the goals and objectives for the FOA, as well as answering questions from webinar attendees.
If you plan to attend the webinar and require accommodation such as a sign language interpreter, please contact [email protected] . Following the webinar, a document highlighting frequently asked questions and corresponding answers will be posted to https://www. niddk.
nih. gov/research-funding/current-opportunities/rfa-dk-20-021 . Meeting Link: https://nih.
zoomgov. com/j/1619515446? pwd=UnkrNWNrZHpGV25mSHFMY1hWVWt5QT09 US: +16692545252,,1619515446#,,,,,,0#,,188154# or +16468287666,,1619515446#,,,,,,0#,,188154# Dial (for higher quality, dial a number based on your current location): US: +1 669 254 5252 or +1 646 828 7666 International numbers available: https://nih.
zoomgov. com/u/abAVSNIKH2 Please direct all inquiries to: Division of Diabetes, Endocrinology and Metabolic Diseases National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Division of Digestive Diseases and Nutrition National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bonnie Burgess-Beusse, Ph. D.
Division of Digestive Diseases and Nutrition National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Division of Kidney, Urologic, and Hematologic Diseases National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Division of Kidney, Urologic, and Hematologic Diseases National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Weekly TOC for this Announcement NIH...
Turning Discovery Into Health ®
According to the current listing, eligibility includes: Scientists and researchers from eligible institutions. Confirm the full requirements in the official notice before applying.
Mechanistic Studies of the Interaction between SARS-Co-V-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (RO1 Clinical Trial Optional) is funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.